Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

„Apollo Group“ planuoja išleisti obligacijas ir jas listinguoti „Nasdaq“ biržoje

Aspire Biopharma Announces $21 Million Private Placement by Select Investors, Strengthening Balance Sheet, Capital Position, and Fortifying Shareholder Equity to Meet Nasdaq Requirements

Nevada Challenge And ARK Rebalancing Reframe Coinbase Regulatory And Earnings Risks

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Buy 2 Vanguard index funds to beat the S&P 500 in the next year, according to Wall Street